PPT-ICTR Drug Discovery and Development Core and Applications to Research
Author : morgan | Published Date : 2022-06-28
Paul Shapiro PhD pshapirorxumarylandedu 4107068522 James Polli PhD jpollirxumarylandedu 4107068292 ICTR Enrichment Seminar October 13 2020 wwwumarylandeduICTR
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "ICTR Drug Discovery and Development Core..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
ICTR Drug Discovery and Development Core and Applications to Research: Transcript
Paul Shapiro PhD pshapirorxumarylandedu 4107068522 James Polli PhD jpollirxumarylandedu 4107068292 ICTR Enrichment Seminar October 13 2020 wwwumarylandeduICTR 2 Agenda. By Andreas Dr Lorenz M.Mayr Drug Discovery World Summer 2006 Miniaturisation ofassay developmentand screening In recent years we have seen a strong increase in the number of chemicalcompounds and mole Presentation . | . October . 2013. The future of drug discovery has arrived. Reducing development time, cost & risk. When used anywhere in this presentation, whether oral or written, the words expects, believes, anticipates, estimates and similar expressions are intended to identify forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of Critical Outcome Technologies Inc. (COTI).. an Industrial Process. How are drugs . discovered and developed?. Dr Steve Carney, s.carney@elsevier.com. Managing Editor, . Drug Discovery Today. What’s my background?. First degree in Biochemistry. – . get ready for the show. Weidong Zhang. Pfizer. 1. Outline. Overview of omics technology. Application of omics in drug discovery. Case studies from pre-clinical to phase II/III. 2. 3. Omics provide paramount view of biological cascade. Properties: . Optimizing Pharmacokinetics and Safety During Drug . Discovery. ACS Short Course. Li Di and Edward H. Kerns. Introduction to Drug-Like Properties. Few research compounds will become drugs because they lack sufficient pharmacokinetics (PK) and safety. Steve Ritland. Shanon Hunt. Holly Hilton. Rutgers . - GSBS PATH N5209. The Business of Science. . From Molecules to Medicines. Fall . 2016. 2. Today’s Agenda. Welcome and Introduction. (Nick. ) . 65. th. Annual . Bohan. Lecture. Scott J. Weir, . PharmD. , PhD. 08 October 2011. Drug Focused Translational Research. Translational Research Defined by the Clinical Problem. Breast Cancer. Clinical Problem. F.I.R.E. Series. 21 October 2013. Rob Clark. Senior Vice President. for Research. &. Dean, . Hajim. School. of Engineering. The Origins of New Medicines. & The Importance of Academic Research & Discovery. Virtual . Screening in Novel Drug . Discovery. cHiPSet. –. . CS. 1. . Final. . Report. Vilnius. , March. . 28-29, . 201. 9. . . Speaker. Drug discovery is.... Important – one could go as far as to assess our development as a society by the coverage of diseases that can be treated. Hybrid . bionanosystems. based on . self-assembled . structures. ,. quantum . dots. ,. . plasmonic. . and magnetic nanoparticles. Strategic . Line of Research at CFUM. Phil. . . Trans. . R. Soc. A . Harrington Discovery Institute. . is designed to identify and resource the most promising physician-scientists and other scientists to accelerate the advancement of their breakthrough discoveries into medicines. The Institute provides . Gerald J. Wyckoff. Training modes. Are we training . genomicists. to deal with the right problems?. Are the training modalities we’re using proper?. What questions should we be looking at?. Problems in Drug Discovery. Provided with the permission of Drug Discovery World Unlocking clinical trial data to uncover new therapeutic opportunities key considerations and best practices This article discusses opportunities Institute . for Clinical and Translational Research. And. Translational Laboratory Cores. Craig Hendrix, MD, . ICTR/CFAR . Lab Core. . Director. chendrix@jhmi.edu, . 410-955-9707. Curt Reynolds, MAS, .
Download Document
Here is the link to download the presentation.
"ICTR Drug Discovery and Development Core and Applications to Research"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents